Epithelial regulation of innate immunity to respiratory syncytial virus

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 5, 2000, Pages 581-585

  Garofalo, R P ^a   Haeberle, H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0033747990     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.5.f204     Document Type: Review

References (46)

1. Recovery of cytopathogenic agent from chimpanzees with coryza
2. Respiratory syncytial virus: A continuing culprit and conundrum
3. Respiratory syncytial virus disease infants despite prior administration of antigenic inactivated vaccine
4. Infectivity of respiratory syncytial virus by various routes of inoculation
5. Clinical aspects of bronchial reactivity and cell-virus interaction
6. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells
7. Cell-specific expression of RANTES, MCP-1, and MIP-1 alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus
8. Effect of glucocorticoids on C3 gene expression by the A549 human pulmonary epithelial cell line
9. Transcriptional control in the developing lung: The Parker B. Francis lectureship
10. Collectins: Collagenous C-type lectins of the innate immune defense system
11. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages
12. Respiratory syncytial virus lung infection in infants: Immuno-regulatory role of infected alveolar macrophages
13. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages: Suppression of early cytokine production and implications for incomplete immunity
14. Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages
15. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity
16. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo
17. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
18. Respiratory syncytial virus replication in human lung epithelial cells: Inhibition by tumor necrosis factor alpha and interferon beta
19. Respiratory Syncytial Virus-inducible activation of the transcription factor NF-κB mediates pulmonary inflammation
20. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study
21. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection
22. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchitis: Relation to asthma and atopy
23. Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection
24. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism
25. An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus
26. Activation of human eosinophils in vitro by respiratory syncytial virus
27. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus
28. Accessory cell function of human eosinophils: HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression
29. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection
30. Respiratory syncytial virus affects pulmonary function in BALB/c mice
31. Interaction of polymorphonuclear leukocytes and viruses in humans: Adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells
32. Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus
33. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells: Roles of CD18 and intercellular adhesion molecule-1
34. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus
35. Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV)
36. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release
37. Simultaneous degranulation of eosinophils and stimulation of neutrophil/macrophage oxidative metabolism is characteristic of bronchiolitis but not other respiratory illnesses
38. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis
39. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
40. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-β and IL-1a
41. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection
42. Natural killer cell response to respiratory syncytial virus in the BALB/c mouse model
43. Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice
44. Beneficial and harmful immune responses in the respiratory tract
45. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: Role of MIP-1a in lung pathology
46. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma